A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Autoimmune

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Changzheng Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Xu Huji) · xuhuji@smmu.edu.cn · +86 21 8188 5514
Contact: Principal Investigator (Xu Huji)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Refractory Autoimmune Diseases

IsraelRecruitingPHASE1

Boston, United States · Durham, United States

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Autoimmune Disorders · Systemic Sclerosis · Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States · Houston, United States

CAR-T Cells Targeting Autoimmune Diseases

Autoimmune Diseases

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China

Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults

Type 1 Diabetes Mellitus · Latent Autoimmune Diabetes in Adult (LADA)

Abroad (travel likely)Recruiting

Pavia, Italy